An important question by shorya sood to which I didn’t have an answer. Hope all in the news media think about and act on this including us.

'I work with patient level data and it is really interesting to see the diversity it holds and how #AI and #ML can help to understand the complexities underlying these diseases', Meemansa Sood reports. Read her full interview at:
s.fhg.de/wisd22
#WomenInScienceDay

Read my Full interview on the #WomeninScienceDay here:

The preliminary results from the devices and apps used in RADAR-AD (gait measured via the Physilog, cognition via the Altoida app, the ability to measure finances via a Banking app) were presented at the digital AAIC 2021 conference: radar-ad.org/newsroom/preli… @IMI_JU Neuronet

Last month Meemansa Sood, PhD student at Fraunhofer SCAI, represented RADAR-AD at the 2021 conference of the International Society for Computational Biology and spoke about the analysis of digital device technology in Alzheimer’s disease using artificial intelligence.

Excited to present our current work on role of digital measures in Alzheimer's Disease at AAIC 2021. If you are attending AAIC and interested in this work, drop by my poster - Clinical Manifestations: Neuropsychology: Hall1 #aaic2021 RADAR-AD Holger Fröhlich Hofmann-Apitius 🇺🇦🇮🇱